Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort studyPedro I. Más-Bermejo, Marta Ayala‐Ávila, Isabel Morgado-Vega et al.|The Lancet Regional Health - Americas|2022Cited by 35
Cuban Abdala Vaccine: Effectiveness in Preventing Severe Disease and Death from COVID-19 in Havana, Cuba; a Cohort StudyPedro Inocencio Más-Bermejo, Marta Ayala‐Ávila, Felix Orlando Dickinson-Meneses et al.|SSRN Electronic Journal|2022Cited by 23
HCV core protein modulates the immune response against the HBV surface antigen in miceJulio Aguilar, Verena Muzio, Nelson Acosta‐Rivero et al.|Biochemical and Biophysical Research Communications|2003Cited by 10
Correction to “Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study” [The Lancet Regional Health – Americas 2022; 16: 100366] https://doi.org/10.1016/j.lana.2022.100366Pedro I. Más-Bermejo, Marta Ayala‐Ávila, Félix O. Dickinson-Meneses et al.|The Lancet Regional Health - Americas|2022Cited by 1